[Form 4] HCA Healthcare, Inc. Insider Trading Activity

HCA Healthcare's CEO and director reported an insider transaction in common stock.

Rhea-AI Filing Summary

HCA Healthcare's CEO and director reported an insider transaction in common stock. On 11/14/2025, the insider made a gift (code G) of 14,830 shares at a reported price of $0, reducing directly held shares to 32,276.

The insider also reports indirect ownership of HCA common stock through several entities, including 14,979 shares held by HD Trust, 16,731 by 2023 GST Trust, 93,088 by 2023 Trust, 178,289 by 2024 GRAT, 200,000 by 2025 GRAT, and 813,320 shares held by an LP. No derivative securities are reported in the derivative securities table.

Insider Trade Summary

14,830 shares gifted

Gift 7 txns

Insider HAZEN SAMUEL N

Role CEO

Type	Security	Shares	Price	Value
Gift	Common Stock	14,830	$0.00	$0.00
holding	Common Stock	--	--	--
holding	Common Stock	--	--	--
holding	Common Stock	--	--	--
holding	Common Stock	--	--	--
holding	Common Stock	--	--	--
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 32,276 shares (Direct); Common Stock — 14,979 shares (Indirect, By HD Trust); Common Stock — 16,731 shares (Indirect, By 2023 GST Trust); Common Stock — 93,088 shares (Indirect, By 2023 Trust); Common Stock — 178,289 shares (Indirect, By 2024 GRAT); Common Stock — 200,000 shares (Indirect, By 2025 GRAT); Common Stock — 813,320 shares (Indirect, By LP)

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did HCA (HCA) report in this Form 4?

The filing shows that HCA Healthcare's CEO and director reported a gift (transaction code G) of 14,830 shares of HCA common stock on 11/14/2025 at a reported price of $0 per share.

How many HCA shares does the insider own directly after the 11/14/2025 transaction?

After the reported gift of 14,830 shares, the insider's direct ownership of HCA common stock is 32,276 shares.

What indirect HCA shareholdings are reported by the insider?

The insider reports indirect ownership of HCA common stock through several entities: 14,979 shares by HD Trust, 16,731 by 2023 GST Trust, 93,088 by 2023 Trust, 178,289 by 2024 GRAT, 200,000 by 2025 GRAT, and 813,320 shares held by an LP.

What is the insider’s role at HCA Healthcare (HCA)?

The reporting person is both a director and an officer of HCA Healthcare, serving as CEO.

Does this HCA Form 4 report any derivative securities transactions?

No derivative securities transactions are listed. The derivative securities table is present but contains no reported acquisitions, dispositions, or holdings.

Is this HCA Form 4 filed by one or multiple reporting persons?

The form indicates it is filed by one reporting person, not by a group.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 11/18/2025 - 06:23 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

HAZEN SAMUEL N

(Last) (First) (Middle)

ONE PARK PLAZA

(Street)

NASHVILLE TN 37203

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
HCA Healthcare, Inc. [ HCA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CEO

3. Date of Earliest Transaction (Month/Day/Year)
11/14/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/14/2025		G		14,830	D	$0	32,276	D
Common Stock								14,979	I	By HD Trust
Common Stock								16,731	I	By 2023 GST Trust
Common Stock								93,088	I	By 2023 Trust
Common Stock								178,289	I	By 2024 GRAT
Common Stock								200,000	I	By 2025 GRAT
Common Stock								813,320	I	By LP

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Kevin A. Ball, Attorney-in-Fact	11/18/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.